Lipid nanoparticle composition and pharmaceutical composition comprising the same

TW202631112APending Publication Date: 2026-08-01ALDEXCHEM KFT
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
ALDEXCHEM KFT
Filing Date
2025-09-23
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001070512_001
    Figure TWG2TA001070512_001
  • Figure TWG2TA001070512_002
    Figure TWG2TA001070512_002
  • Figure TWG2TA001070512_003
    Figure TWG2TA001070512_003
Patent Text Reader

Abstract

after administration of a luminescent cargo, when the different weights of spleen and liver are taken into account. In the LNP composition, a silicon-containing ionizable lipid is combined with a certain structural lipid, a helper lipid, a shield lipid and a fifth lipid component. The invention describes the production and characterization of the lipid nanoparticles and in vivo experiments demonstrating that the corresponding formulations with LipexSil lipids as described in WO2024 / 023174 are superior to the current approach, delivering their cargo (e.g. RNA, DNA, mRNA, microRNA, siRNA, ceDNA, pDNA, circular DNA, small biologically active molecules) preferentially to the spleen.
Need to check novelty before this filing date? Find Prior Art